Cytomx Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Cytomx Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cytomx Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytomx Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $7.6M | 4.9M | 1.55 |
| 2023-09-30 | $6.3M | 4.9M | 1.29 |
| 2023-06-30 | $8.4M | 4.9M | 1.72 |
| 2023-03-31 | $7.4M | 4.9M | 1.51 |
| 2022-12-31 | $7.3M | 4.6M | 1.60 |
| 2022-06-30 | $9.3M | 5.1M | 1.83 |
| 2022-03-31 | $14M | 5.2M | 2.67 |
| 2021-09-30 | $28M | 5.5M | 5.09 |
| 2021-06-30 | $34M | 5.4M | 6.33 |
| 2021-03-31 | $36M | 4.7M | 7.73 |
| 2020-12-31 | $19M | 2.9M | 6.54 |
| 2020-09-30 | $19M | 2.9M | 6.65 |
| 2020-06-30 | $22M | 2.7M | 8.33 |
| 2020-03-31 | $21M | 2.7M | 7.67 |
| 2019-12-31 | $22M | 2.7M | 8.31 |
| 2019-09-30 | $19M | 2.6M | 7.24 |
| 2019-03-31 | $26M | 2.4M | 10.75 |
| 2018-12-31 | $22M | 1.5M | 15.17 |
| 2018-09-30 | $46M | 2.5M | 18.50 |
| 2018-06-30 | $48M | 2.1M | 22.86 |
| 2018-03-31 | $42M | 1.5M | 28.45 |
| 2017-12-31 | $25M | 1.2M | 21.11 |
| 2017-09-30 | $21M | 1.1M | 18.18 |
| 2017-06-30 | $14M | 924k | 15.50 |
| 2017-03-31 | $14M | 824k | 17.28 |
| 2016-12-31 | $8.8M | 796k | 11.00 |
| 2016-09-30 | $12M | 785k | 15.68 |
| 2016-06-30 | $3.8M | 372k | 10.21 |
| 2015-12-31 | $4.2M | 199k | 20.85 |